- Filed
- Apr 29, 2026 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2026 · Apr 24, 2026 | 94.9M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2026 | 121.03M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2025 | 107.08M sh |
| Stock Repurchased | Q1 2026 · Mar 31, 2026 | $145.22M |
| Stock Repurchased | Q1 2026 · Mar 31, 2025 | $189.18M |
| Capex | Q1 2026 · Mar 31, 2026 | $1.48M |
| Capex | Q1 2026 · Mar 31, 2025 | $3.25M |
| Operating Cash Flow | Q1 2026 · Mar 31, 2026 | $80.74M |
| Operating Cash Flow | Q1 2026 · Mar 31, 2025 | $49.18M |
| Long Term Debt | Q1 2026 · Mar 31, 2026 | $2.33B |
| Long Term Debt | Q1 2026 · Dec 31, 2025 | $2.33B |
| Short Term Debt | Q1 2026 · Mar 31, 2026 | $649.3M |
| Short Term Debt | Q1 2026 · Dec 31, 2025 | $649.01M |
| Cash And Equivalents | Q1 2026 · Mar 31, 2026 | $1.21B |
| Cash And Equivalents | Q1 2026 · Dec 31, 2025 | $1.36B |
| Cash And Equivalents restated | Q1 2026 · Mar 31, 2025 | $617.88M |
| Stockholders Equity | Q1 2026 · Mar 31, 2026 | −$1.14B |
| Stockholders Equity | Q1 2026 · Dec 31, 2025 | −$1.1B |
| Stockholders Equity | Q1 2026 · Mar 31, 2025 | −$910.3M |
| Stockholders Equity | Q1 2026 · Dec 31, 2024 | −$758.87M |
| Current Liabilities | Q1 2026 · Mar 31, 2026 | $1.25B |
| Current Liabilities | Q1 2026 · Dec 31, 2025 | $1.36B |
| Total Liabilities | Q1 2026 · Mar 31, 2026 | $3.82B |
| Total Liabilities | Q1 2026 · Dec 31, 2025 | $3.93B |
| Current Assets | Q1 2026 · Mar 31, 2026 | $2.11B |
| Current Assets | Q1 2026 · Dec 31, 2025 | $1.96B |
| Total Assets | Q1 2026 · Mar 31, 2026 | $2.68B |
| Total Assets | Q1 2026 · Dec 31, 2025 | $2.83B |
| Eps Diluted | Q1 2026 · Mar 31, 2026 | $0.60 |
| Eps Diluted | Q1 2026 · Mar 31, 2025 | −$0.49 |
| Eps Basic | Q1 2026 · Mar 31, 2026 | $0.72 |
| Eps Basic | Q1 2026 · Mar 31, 2025 | −$0.49 |
| Sga Expense | Q1 2026 · Mar 31, 2026 | $62.46M |
| Sga Expense restated | Q1 2026 · Mar 31, 2025 | $73.91M |
| Rd Expense | Q1 2026 · Mar 31, 2026 | $99.05M |
| Rd Expense restated | Q1 2026 · Mar 31, 2025 | $100.81M |
| Net Income | Q1 2026 · Mar 31, 2026 | $69.68M |
| Net Income | Q1 2026 · Mar 31, 2025 | −$52.1M |
| Operating Income | Q1 2026 · Mar 31, 2026 | $119.85M |
| Operating Income restated | Q1 2026 · Mar 31, 2025 | −$3.87M |
| Gross Profit | Q1 2026 · Mar 31, 2026 | $455.6M |
| Gross Profit restated | Q1 2026 · Mar 31, 2025 | $444.4M |
| Cost Of Revenue | Q1 2026 · Mar 31, 2026 | $175.68M |
| Cost Of Revenue restated | Q1 2026 · Mar 31, 2025 | $167.8M |
| Revenue | Q1 2026 · Mar 31, 2026 | $631.28M |
| Revenue restated | Q1 2026 · Mar 31, 2025 | $612.2M |